N-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide for Identifying Coronary Artery Disease and Left Ventricular Hypertrophy in Ambulatory Chronic Kidney Disease Patients-Reference-Cited by-同舟云学术

N-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide for Identifying Coronary Artery Disease and Left Ventricular Hypertrophy in Ambulatory Chronic Kidney Disease Patients

Published:2006-05 Issue:10 Volume:97 Page:1530-1534
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Khan Ijaz A.,Fink Jeffrey,Nass Caitlin,Chen Hegang,Christenson Robert,deFilippi Christopher R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency;Culleton;Kidney Int,1999

2. Prevalent left ventricular hypertrophy in the predialysis population;Levin;Am J Kidney Dis,1996

3. Cardiovascular mortality risk in chronic kidney disease;Shlipak;JAMA,2005

4. B-Type natriuretic peptide and ischemia in patients with stable coronary disease;Bibbins-Domingo;Circulation,2003

5. N-terminal B-type natriuretic peptide predicts the extent of coronary artery disease and ischemia in patients with stable angina pectoris;Weber;Am Heart J,2004

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial;BMJ Open;2024-08

2. The Role of N-Terminal-Pro-B-Type Natriuretic Peptide (NT-proBNP) and High-Sensitivity Troponin T (Hs-Troponin T) in the Evaluation of the Syntax Score in Patients With Acute Coronary Syndrome;Cureus;2024-03-06

3. NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease;Clinical and Experimental Nephrology;2024-01-19

4. Argumentaire pour l’utilisation du dosage sanguin des biomarqueurs cardiaques en hémodialyse : les peptides natriurétiques et les troponines;Néphrologie & Thérapeutique;2023-08-01

5. Applications of cardiac biomarkers in chronic kidney disease;Current Opinion in Nephrology & Hypertension;2022-08-04